Former FDA commissioner says U.S. may be unable to decrease coronavirus transmission much more

Former Food and Drug Administration Commissioner Scott Gottlieb believes the United States may not be able to reduce coronavirus transmission much more, saying we should prepare for a "new normal."
Gottlieb spoke with Today on Tuesday as many states allow some nonessential businesses to begin reopening and after a key model that's been cited by the White House significantly raised its projected death toll from COVID-19 to almost 135,000 by early August.
"We still have a high level of infection in this country," Gottlieb said. "We've reached a plateau, but we haven't seen the kind of declines that we were expecting to see at this point. And as we start to reopen the country, cases are likely to go up, not down."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Gottlieb went on to suggest that as cases continue to rise in many states, the country may not be able to lower the rate of infection much further.
"I think that we need to understand, this may be the new normal," he said. "We may not be able to get transmission down much more. I hope we can."
Gottlieb expanded on this in a Twitter thread, in which he wrote that "we need to prepare to deal with covid as a persistent threat," including by protecting those who are most vulnerable and being "prepared with case-based interventions, and widespread screening, to slow the transmission."
On Monday, The New York Times reported that the Trump administration is privately forecasting that the U.S. daily coronavirus death toll will reach 3,000 by June 1, up from about 1,750, as well as 200,000 new cases a day by the end of the month, up from about 25,000. Brendan Morrow
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
US foodies brace for tariff war
Under The Radar Shoppers stocking up on imported olive oil, maple syrup and European wine as price hikes loom
By Chas Newkey-Burden, The Week UK Published
-
How Canadian tariffs could impact tourism to the US
In the Spotlight Canadians represent the largest group of foreign visitors to the United States. But they may soon stop visiting.
By Justin Klawans, The Week US Published
-
Entitlements: DOGE goes after Social Security
Feature Elon Musk is pushing false claims about Social Security fraud
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published